ReviewJMIR XR and spatial computing2025
Virtual Reality Reminiscence Therapy in Dementia Care: Scoping Review of Research.
Review in JMIR XR and spatial computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dementia is a progressive neurological disorder affecting cognitive and social functioning, posing challenges for patients and caregivers. Traditional medications often have adverse effects, emphasizing the need for nonpharmacological options such as reminiscence therapy (RT). Virtual reality (VR) has emerged as a promising tool in dementia care, providing immersive experiences that stimulate memory, enhance emotional well-being, and reduce the behavioral and psychological symptoms of dementia. Objective: This scoping review assesses the feasibility and implementation challenges of delivering RT via VR in dementia care. Specifically, it examines the types of VR systems used, their therapeutic benefits, and the barriers to their adoption. Methods: We screened 5 electronic libraries: Google Scholar, ACM Digital Library, IEEE Xplore, MEDLINE, and PubMed. Studies published between 2000 and 2025 were included if they examined the use of VR for RT in people with dementia. Data were charted based on PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) guidelines and analyzed thematically for feasibility, VR system type, therapeutic effects, and implementation considerations. Results: A total of 15 studies met the inclusion criteria. The findings indicate that VR is feasible and well-accepted among people with dementia, fostering high engagement with minimal adverse effects. Fully immersive VR systems, which use head-mounted displays, are the most frequently used, while semi-immersive alternatives with large screens provide a more cost-effective option. RT via VR has been shown to improve reminiscence, enhance mood, and encourage social interaction. However, its impact on cognitive function remains inconclusive. Significant barriers to implementation include high costs, limited availability of VR infrastructure in care, and the need for specialized caregiver training. Conclusions: RT via VR presents a promising advancement in dementia care. Future research should focus on developing cost-effective, scalable VR solutions, designing personalized VR experiences tailored to individual needs, and creating structured training programs for caregivers. Longitudinal studies are necessary to determine the long-term therapeutic effects of VR compared to traditional RT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.